| Prevalencia de prediabetes y diabetes en México: Ensanut 2022 A Basto-Abreu, N López-Olmedo, R Rojas-Martínez, CA Aguilar-Salinas, ... salud pública de méxico 65, s163-s168, 2023 | 63 | 2023 |
| A bioinformatic prediction of antigen presentation from SARS‐CoV‐2 spike protein revealed a theoretical correlation of HLA‐DRB1* 01 with COVID‐19 fatality in Mexican population … JP Romero‐López, M Carnalla‐Cortés, DL Pacheco‐Olvera, ... Journal of Medical Virology 93 (4), 2029-2038, 2021 | 55* | 2021 |
| Enfermedad vascular cerebral isquémica: revisión extensa de la bibliografía para el médico de primer contacto JA Choreño-Parra, M Carnalla-Cortés, P Guadarrama-Ortíz Medicina interna de México 35 (1), 61-79, 2019 | 54 | 2019 |
| Acceptance, refusal, and hesitancy of Covid-19 vaccination in Mexico: Ensanut 2020 Covid-19 M Carnalla, A Basto-Abreu, D Stern, S Bautista-Arredondo, ... Salud publica de Mexico 63 (5), 598-606, 2021 | 49* | 2021 |
| Nationally representative SARS-CoV-2 antibody prevalence estimates after the first epidemic wave in Mexico A Basto-Abreu, M Carnalla, L Torres-Ibarra, M Romero-Martínez, ... Nature Communications 13 (1), 589, 2022 | 33* | 2022 |
| SARS-CoV-2 infection fatality rate after the first epidemic wave in Mexico L Torres-Ibarra, A Basto-Abreu, M Carnalla, R Torres-Alvarez, ... International journal of epidemiology 51 (2), 429-439, 2022 | 20 | 2022 |
| Expression of surfactant protein d distinguishes severe pandemic influenza A (H1N1) from coronavirus disease 2019 JA Choreño-Parra, LA Jiménez-Álvarez, G Ramírez-Martínez, ... The Journal of infectious diseases 224 (1), 21-30, 2021 | 17 | 2021 |
| Revisión rápida: monitoreo de la presencia e infectividad del virus SARS-CoV-2 y otros coronavirus en aguas residuales C Cruz-Cruz, S Rodríguez-Dozal, M Cortez-Lugo, M Ovilla-Muñoz, ... salud pública de méxico 63 (1), 109-119, 2021 | 11 | 2021 |
| Abordaje del paciente con traumatismo craneoencefálico: un enfoque para el médico de primer contacto. Atenc Famil [Internet]. 2018 [citado 23/10/2021]; 26 (1): 28-33 AM Cruz-López, A Ugalde-Valladolid, CA Aparicio-Ambriz, ... | 8 | |
| Patrones de consumo de alcohol en adolescentes y adultos mexicanos: Ensanut Continua 2022 Y Ramírez-Toscano, F Canto-Osorio, M Carnalla, MA Colchero, ... salud pública de méxico 65, s75-s83, 2023 | 7* | 2023 |
| Comparable diagnostic accuracy of SARS-CoV-2 Spike RBD and N-specific IgG tests to determine pre-vaccination nation-wide baseline seroprevalence in Mexico J Martínez-Barnetche, M Carnalla, C Gaspar-Castillo, A Basto-Abreu, ... Scientific Reports 12 (1), 18014, 2022 | 6 | 2022 |
| Prevalencia de anticuerpos y vacunación contra SARS-CoV-2 en 2022 en México M Carnalla, A Basto-Abreu, D Stern, MA Colchero, S Bautista-Arredondo, ... salud pública de méxico 65, s135-s145, 2023 | 5 | 2023 |
| Prevalence of hepatitis C in the adult Mexican population: National Survey of Health and Nutrition 2018 M Carnalla, T Barrientos-Gutiérrez, D Vidaña-Perez, M Romero-Martínez, ... The Lancet Regional Health–Americas 8, 2022 | 5 | 2022 |
| Reduction of HPV16/18 prevalence in young women after eight years of three-and two-dose vaccination schemes M Carnalla, L Torres-Ibarra, T Barrientos-Gutiérrez, A Cruz-Valdez, ... Vaccine 39 (32), 4419-4422, 2021 | 5 | 2021 |
| Probióticos¿ coadyuvantes en el tratamiento médico? P Guadarrama-Ortíz, JC Flores-Vázquez, M Carnalla-Cortés, ... Medicina interna de México 34 (4), 574-581, 2018 | 5 | 2018 |
| Anticuerpos monoclonales contra el CGRP para el tratamiento de la migraña crónica y episódica. JA Choreño-Parra, M Carnalla-Cortés, N Martínez-Zúñiga Revista Mexicana de Neurociencia 19 (4), 2018 | 5 | 2018 |
| Hepatitis B infection in Mexican adults: Results of a nationally representative survey M Carnalla, D Vidana-Perez, C Alpuche-Aranda, NC Chávez-Tapia, ... Annals of Hepatology 27, 100583, 2022 | 4 | 2022 |
| Sex work and high-risk anal human papillomavirus infection among transgender women: The Condesa Study AJ Portillo-Romero, B Allen-Leigh, AG Nyitray, M Carnalla, J Salmerón, ... Transgender Health 6 (6), 315-324, 2021 | 3 | 2021 |
| The effect of a booster dose of HPV tetravalent vaccine after 51 months: implications for extended vaccination schedules E Lazcano-Ponce, M Carnalla-Cortés, T Barrientos-Gutiérrez, ... salud pública de méxico 60 (6), 666-673, 2018 | 3 | 2018 |
| Prevalence and development of a risk score for oral human papillomavirus infection in men who have sex with men in Mexico M Carnalla, R Rojas‐Martínez, T Barrientos‐Gutiérrez, B Allen‐Leigh, ... Journal of Oral Pathology & Medicine 52 (8), 751-757, 2023 | 2 | 2023 |
Tonatiuh Barrientos-GutierrezNational Institute of Public HealthVerified email at insp.mx
